Skip to main content
. 2025 Jan 14;31(2):101292. doi: 10.3748/wjg.v31.i2.101292

Figure 2.

Figure 2

Histograms demonstrates the distribution of vedolizumab serum trough concentrations. A: At week 0; B: At week 48; C: Scatter plot illustrates the relationship between vedolizumab serum trough concentrations at week 0 and week 48, categorized by thiopurine use.